A week ahead of schedule, the FDA approved the nation's first cell therapy for advanced melanoma on Feb. 16. 

The prevalence of polypharmacy — or overlapping prescriptions of psychiatric drugs — is growing among children and adolescents, new findings from a Maryland study suggest. 

Avesi Partners ("Avesi") announced that it has made an investment in Visante (or the "Company"), a leading provider of specialized tech-enabled consulting and advanced partnership services focused on helping health systems accelerate financial and operational performance through their pharmacy offerings. Avesi has partnered…

In the first 10 months of 2023, 1,268 Wegovy prescriptions were written for adolescents with obesity — a more than 50-fold increase from 2022, according to an exclusive Reuters report. 

A COVID-19 antiviral therapy authorized in Japan, ensitrelvir, shortened the duration of symptoms from five days to four days in a phase 3 study.

Senators are urging the FDA to update decade-old guidance and take action to rein in social media advertisements of prescription drugs from telehealth companies, requesting that the agency respond to their concerns by March 27, according to a Feb. 15…

The Federal Trade Commission and HHS launched an investigation Feb. 14 into how group purchasing organizations and drug wholesalers might cause drug shortages. 

Mark Cuban Cost Plus Drug Co. now offers critical drugs in shortage to healthcare providers. 

Harvard University researchers have received $1.2 million from CARB-X, a Boston University-led nonprofit that funds projects that focus on drug-resistant bacteria named on the CDC’s Antibiotic Resistant Threats list.

The FDA has sent warning letters to two online vendors — US Chem Labs and Helix Chemical Supply — for selling unapproved and misbranded versions of semaglutide and tirzepatide.